| 摘要 |
A method of treating a proliferative disease in an individual comprising administering to the individual: a) An effective amount of a composition comprising nanoparticles comprising a taxane and an albumin, and b) An effective amount of at least one other chemotherapeutic agent, wherein said chemotherapeutic agent is selected from the group consisting of antimetabolites, platinum based agents, acylating agents, tyrosine kinase inhibitors, anthracycline antibiotics, vinca alkaloids, proteasome inhibitors, macrolides and topoisomerase inhibitors. |
